Dr. Corrales joined at Point Guard Partners in July 2013. Before this position, she was a Scientist at the Ocular Surface Center, part of the Cullen Eye Institute at Baylor College of Medicine, Houston, TX from March 2003 to December 2006 and from July 2009 to July 2013. Dr. Corrales’s groundbreaking research into dry eye disease focuses on identifying specific genes or proteins that are involved in causing the damage to the ocular surface of the eye. Her research has identified molecular targets for therapy of dry eye disease as well as better methods to diagnose the condition.
Prior this position, she was leading projects on stem cell therapy and regenerative medicine at the Institute of Applied Ophthalmobiology (IOBA) in the University of Valladolid, Valladolid, Spain (2006-2009), where she was the Director of the Molecular Biology Lab of this Institute, focused mainly in the diagnosis of clinical infectious diseases in ocular samples as well as in helping other researchers with the needed molecular biology techniques for the development of their projects. During this time she diagnosed more than 300 samples from patients and she collaborated as much in the experimental part as in the analysis of results in 14 research projects.
Dr. Corrales received her Ph.D. in Molecular Biology from IOBA in 2002 with the maximum grade: “Sobresaliente Cum Laude” and she also received two different Prizes for her thesis titled: "Modulation of the expression of human conjuntival mucin genes by topic cyclosporin A. Study in vivo and vitro." She has over 16 years of research experience in Ophthalmology from basic to translational research (more than 40 projects). She has published more than 35 papers in peer-reviewed journals, authored 85 international meeting presentations and holds 3 patents in the area of ocular surface diseases. She’s a respected peer reviewer of 16 journals and book editor.